ASTEX
LIVE

Serial Number

79432262

Owner

Astex Therapeutics Limited

Attorney

Carole E. Klinger

Filing Date

Jul 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ASTEX Trademark

Serial Number: 79432262

ASTEX is a trademark filed by Astex Therapeutics Limited on July 18, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Astex Therapeutics Limited

436 Cambridge Science Park,

Entity Type: 99

Trademark Details

Filing Date

July 18, 2025

Registration Date

Not Registered

Published for Opposition

June 9, 2026

Goods & Services

Recorded and downloadable computer software used for drug discovery in the field of drug discovery research and pharmaceutical drug development; recorded and downloadable computer software used for biotechnology research in the field of drug discovery and pharmaceutical drug development; recorded and downloadable computer software used for scientific analysis in the field of drug discovery and pharmaceutical drug development; recorded and downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis in the field of drug discovery and pharmaceutical drug development; recorded and downloadable computer software applications for use in designing and developing artificial intelligence, information technology, deep learning, machine learning, and reinforcement learning for use in drug discovery, biotechnology research and scientific analysis; recorded and downloadable computer programs and software algorithms for use in manipulating received or inputted data generated in a virtual space for use in connection with artificial intelligence methods, natural language processing, natural language understanding, natural language human-machine interfaces and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for use in software development in the field of drug discovery, biotechnology research and scientific analysis

Providing health care information via telephone and the internet; providing information in the field of the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals.

Pharmaceutical drug development services; drug discovery services; biotechnology research; scientific research and analysis in the field of drug discovery and pharmaceutical drug development; providing scientific health care research information in the field of pharmaceuticals and clinical trials; research and development in the field of pharmaceuticals

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 9, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jun 9, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 3, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 11, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 8, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 8, 2026 TROA
REFUSAL PROCESSED BY IB
Feb 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 20, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 20, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 17, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 16, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 5, 2025 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
APPLICATION FILING RECEIPT MAILED
Sep 21, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 21, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 11, 2025 REPR